Items tagged with Drug-resistant TB
Newest MDR-TB drug prices could fall by up to 95% through generic production (post with simple image)
The cost of newer drugs for the treatment of multidrug-resistant tuberculosis could be cut by up to 95% if generic production of patented products could be achieved in the same way as for antiretroviral drugs.
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid (post with simple image)
As countries improve and scale up their diagnostic services, increasing number of patients with multidrug-resistant TB and extensively drug-resistant TB are identified. Bedaquiline and delamanid offer a real opportunity to improve the outcomes of these patients. After so many decades without new TB drugs the development of these two new medicines is an historic opportunity to gain ground in the fight against TB.
Do we have the will to stop TB? (post with simple image)
Doctors swear to do no harm, but I knew I was about to inflict great suffering on my patient Gary, who had been diagnosed with extensively drug-resistant tuberculosis, or XDR TB. Many people wrongly assume that tuberculosis has been eradicated. In fact, according to the World Health Organization, tuberculosis killed more people in 2015 than HIV/AIDS.
Time for White House to step up on TB (post with simple image)
The World Health Organization just released new data showing tuberculosis kills more people than even HIV/AIDS, and it called multidrug-resistant TB a public health crisis.
First new TB drugs in half a century reach just 2% of people who need them (post with simple image)
Médecins Sans Frontières calls for companies to make new drugs to treat drug-resistant TB, bedaquiline and delamanid, available and affordable.
New cohort study shows promise of dramatically shorter treatment option for multidrug-resistant TB (post with simple image)
Initial results show 80% success rate using 9-month treatment option for MDR-TB, compared with 24-month treatment standard.
Obama Administration releases National Action Plan for Combating Multidrug-Resistant Tuberculosis (post with simple image)
The White House released a comprehensive action plan identifying a set of targeted interventions that address the core domestic and global challenges posed by multidrug-resistant and extensively drug-resistant tuberculosis.
Urgent need to make linezolid available in South Africa at affordable price (post with simple image)
TB advocates urge pharmaceutical companies to register their respective linezolid products in South Africa and make them available at an affordable price.
TAG’s response to the U.S. Action Plan for Combating Multidrug-Resistant Tuberculosis (post with simple image)
The targets set forth in the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis are not ambitious enough to effectively stop the spread of multidrug-resistant tuberculosis.
Lancet Series on access to and sustainable effectiveness of antimicrobials (post with simple image)
The Lancet published a Series of five papers examining access to and sustainable effectiveness of antimicrobials.
Page 67 of 73 · Total posts: 0←First 66 67 68 Last→